TITLE

Review: Anti-tumor necrosis factor antibody therapy for rheumatoid arthritis increases risk for serious infection and malignancy

PUB. DATE
November 2006
SOURCE
ACP Journal Club;Nov/Dec2006, Vol. 145 Issue 3, p65
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
The article presents information on a medical study related to the anti-tumor necrosis factor (anti-TNF) antibody therapy for rheumatoid arthritis. When the study was carried out in patients with rheumatoid arthritis, TNF antibody therapy increased risk for both serious infection and malignancy more than placebo.
ACCESSION #
23245690

 

Related Articles

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics